Form 4: Tyra Biosciences CFO Receives Stock Grant
Insider Transaction (Form 4)
Alan Fuhrman, Chief Financial Officer of Tyra Biosciences, Inc., received 951 shares of common stock on September 15, 2026.
Summary
- Grant/award: acquired 951 Common Stock at $9.13 ($8,682) on September 15, 2026; holds 37,115 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Alan Fuhrman — Officer (Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-15 | Grant/award | Common Stock | 951 | $9 | $8.7K | 37,115 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-15 | Grant/award (951 shares) |
Keywords
insider transaction, Form 4, TYRA, Tyra Biosciences, Inc., neutral, Alan Fuhrman
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.